MedPath

Comparison of the effect of electrosurgery with cryosurgery in the treatment of sebaceous hyperplasia, seborrheic keratosis, cherry angioma and skin tag

Phase 2
Conditions
Condition 1: sebaceous hyperplasia. Condition 2: seborrheic keratosis. Condition 3: cherry angioma. Condition 4: skin tag.
Other specified follicular disorders
Seborrheic keratosis
Hemangioma of skin and subcutaneous tissue
Other hypertrophic disorders of the skin
L73.8
D18.01
L91.8
Registration Number
IRCT20211210053344N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
128
Inclusion Criteria

Confirmation of diagnosis with a clinical examination by a dermatologist
Age 18 to 70 years

Exclusion Criteria

Infection of the lesion site
History of keloid
Pregnancy and Lactation
Malignancy
Immunosuppression
For electrosurgery: having an intracardiac device
For cryosurgery: cold intolerance, history of Raynaud's phenomenon, vesiculobullous diseases and superficial sensory involvement

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
esion size. Timepoint: At the beginning of the study, 2 weeks, 1 month and 3 months later. Method of measurement: with a ruler.;The rate of improvement. Timepoint: 2 weeks, 1 month and 3 months after the beginning. Method of measurement: based on evaluation of a blind dermatologist.
Secondary Outcome Measures
NameTimeMethod
Safety. Timepoint: 2 weeks, 1 month and 3 months after the beginning. Method of measurement: based on side effects of the treatment (clinical evaluation).;Tolerability. Timepoint: 2 weeks, 1 month and 3 months after the beginning. Method of measurement: based on Investigator Assessment of Tolerability scale.;Satisfaction. Timepoint: 2 weeks, 1 month and 3 months after the beginning. Method of measurement: based on Caregiver treatment satisfaction (CTS) questionnaire.
© Copyright 2025. All Rights Reserved by MedPath